p53 accelerates endothelial cell senescence in diabetic retinopathy by enhancing FoxO3a ubiquitylation and degradation via UBE2L6
Experimental Gerontology · 2024
DOI: 10.1016/j.exger.2024.112391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Gerontology, 2024. Verfasst von Ying Cheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of En…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Diabetic Retinopathy. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: TianJin Education Committee.
Abstract (Originalsprache)
Diabetic retinopathy (DR) is the most common ocular fundus disease in diabetic patients. Chronic hyperglycemia not only promotes the development of diabetes and its complications, but also aggravates the occurrence of senescence. Previous studies have shown that DR is associated with senescence, but the specific mechanism has not been fully elucidated. Here, we first detected the differentially expressed genes (DEGs) and cellular senescence level of db/db mouse retinas by bulk RNA sequencing. Then, we used single-cell sequencing (scRNA-seq) to identify the main cell types in the retina and analyzed the DEGs in each cluster. We demonstrated that p53 expression was significantly increased in retinal endothelial cell cluster of db/db mice. Inhibition of p53 can reduce the expression of SA-β-Gal and the senescence-associated secretory phenotype (SASP) in HRMECs. Finally, we found that p53 can promote FoxO3a ubiquitination and degradation by increasing the expression of the ubiquitin-conjugating enzyme UBE2L6. Overall, our results demonstrate that p53 can accelerate the senescence process of endothelial cells and aggravate the development of DR. These data reveal new targets and insights that may be used to treat DR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, China.
- NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, China. Electr…
Förderung
- TianJin Education Committee
Zitieren
APA
Cheng, Y., Zhang, M., Xu, R., Fu, L., Xue, M., Xu, C., Tang, C., Fang, T., Liu, X., Sun, B., & Chen, L. (2024). p53 accelerates endothelial cell senescence in diabetic retinopathy by enhancing FoxO3a ubiquitylation and degradation via UBE2L6. Experimental Gerontology. https://doi.org/10.1016/j.exger.2024.112391
Vancouver
Cheng Y, Zhang M, Xu R, Fu L, Xue M, Xu C, et al. p53 accelerates endothelial cell senescence in diabetic retinopathy by enhancing FoxO3a ubiquitylation and degradation via UBE2L6. Experimental Gerontology. 2024. doi:10.1016/j.exger.2024.112391
BibTeX
@article{Cheng2024,
author = {Cheng, Ying and Zhang, Man and Xu, Rong and Fu, Lingli and Xue, Mei and Xu, Chaofei and Tang, Chao and Fang, Ting and Liu, Xiaohuan and Sun, Bei and Chen, Liming},
title = {p53 accelerates endothelial cell senescence in diabetic retinopathy by enhancing FoxO3a ubiquitylation and degradation via UBE2L6},
journal = {Experimental Gerontology},
year = {2024},
doi = {10.1016/j.exger.2024.112391}
}
EUVIMED